Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)

NCT01231633 NA COMPLETED Results posted

The purpose of this study is to compare visual improvement and total number of intraocular injections in eyes with macular edema following central retinal vein occlusion (CRVO)after initial treatment with Ozurdex (dexamethasone implant) or Avastin (bevacizumab).

Details

Lead sponsor	Long Island Vitreoretinal Consultants
Phase	NA
Status	COMPLETED
Enrolment	27
Start date	2010-09
Completion	2014-09

Conditions

• Macular Edema
• Central Retinal Vein Occlusion

Interventions

• Ozurdex
• Avastin

Primary outcomes

• The Change in Visual Acuity (Number of ETDRS Early Treatment Diabetic Retinopathy Study Letters), at Month 6 as Compared With Baseline in Each Treatment Arm — Baseline - Month 6
  The change in visual acuity (number of ETDRS - Early Treatment Diabetic Retinopathy Study letters), at Month 6 as compared with baseline in each treatment arm
• The Total Number of Additional Avastin Injections Following Initial Treatment in Each Treatment Arm — Baseline - Month 6
  Total Number of addiitonal Avastin injections during study- From baseline to Month 6

Countries

United States